Results 141 to 150 of about 18,028 (178)

Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). [PDF]

Front Pharmacol
Zhao B, Zhou X, Zheng P, Zhang B, Feng X, Chen J, Cai L, Chen Y, He L, Su J, Cheng S, Zeng Y, Li G, Ji B, Wu J, Feng W, Liu M, Jin Y, Liu T, Mo X, Wu J, Wu H, Zhang H, Zheng Z, Zheng Z, Sun J, Li Y, Guangdong Pharmaceutical Association, Hematology Group of Rare Disease Expert Committee of Guangdong Pharmaceutical Association.   +28 more
europepmc   +1 more source

Recurrent pneumothoraces in a patient with pulmonary Langerhans cell histiocytosis accompanied with unexpected histological changes. [PDF]

Arch Clin Cases
Tan C, Sundaram P.
europepmc   +1 more source

Unveiling Langerhans cell histiocytosis presenting as hidradenitis suppurativa: A case report and systematic review. [PDF]

Int J Surg Case Rep
Mohammadzadeh I, Bazgir N, Niroomand B, Khodabakhsh G, Akbari N, Mousavinejad SA.   +5 more
europepmc   +1 more source

Prevalence of Gastroesophageal Reflux in Interstitial Lung Diseases Clinic. [PDF]

Cureus
Akhter N, Sumalani KK, Chawla D, Rizvi N.   +3 more
europepmc   +1 more source

Atypical jaw swelling in children: An unusual clinical spectrum of Langerhans cell histiocytosis. [PDF]

J Oral Maxillofac Pathol
Sithara K, Balan U, Mohammed PR, Stanly AS.   +3 more
europepmc   +1 more source

Overlap syndrome of Erdheim-Chester disease and Langerhans cell histiocytosis: A case report.

Cytojournal
Ding Y, Chen S, Huang G, Guo X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non‐Langerhans cell histiocytosis: Case report and literature review

Journal of cutaneous pathology, 2023
Cutaneous non‐Langerhans cell histiocytosis (NLCH) is a rare and biologically benign entity that can be broadly classified into two categories: xanthogranuloma and non‐xanthogranuloma.
Folasade F Fayiga, S. Reyes-Hadsall, Brian A Moreno, K. Oh, Carole Brathwaite, A. Duarte   +5 more
semanticscholar   +1 more source

A novel GAB2::BRAF fusion in cutaneous non‐Langerhans‐cell histiocytosis with systemic involvement

Journal of cutaneous pathology, 2022
Several mutations and gene fusions involved in the mitogen‐activated protein kinase (MAPK) pathway have been reported in histiocytic neoplasms including Langerhans cell histiocytosis and non‐Langerhans‐cell histiocytosis (NLCH).
Bicong Wu, E. Konnick, E. Kimble, P. Hendrie, M. Shinohara, Ata S. Moshiri   +5 more
semanticscholar   +1 more source

Non‐Langerhans cell histiocytosis xanthogranuloma patient with varying histopathology leading to progressive nodular histiocytosis

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021
Subclassifying non-Langerhans cell histiocytosis (non-LCH) had been controversial for several decades. Zelger et al. suggested the concept of classifying non-LCH according to the morphology of predominant histiocytes [1].
Y. Oh, Jemin Kim, C. Park
semanticscholar   +1 more source